Abstract
Rhodopsin is the membrane receptor responsible for photoreception in the vertebrate retina. Over 120 point mutations in rhodopsin are found to be related with autosomal dominant retinitis pigmentosa (ADRP) and the congenital stationary night blindness (CNSB). Despite of several mutations with intense studies, like P23H, a majority of rhodopsin mutations still need further investigations. In order to have extensive and quick functional characterization of these mutations, here we utilize fluorescence imaging to monitor rhodopsin cellular distribution, which reveals to us much useful information, like if rhodopsin has normal transportation to the cell membrane, interrrupted glycosylation or protein aggregates formation. The experiments are carried out through the following process: First, a series of human rhodopsin mutations were constructed, which include mutations responsible for both ADRP and CNSB, like G89D and G90D. Second, wild-type rhodopsin was expressed in 293S GnTi- cells with homogeneous N-glycosylation for protein detection, T-REx293 cells for glycosylation analysis, and Hela cells for immunofluorescence imaging seperately. Third, we also engineered a fusion protein rho-EGFP for in vivo study, with a green fluorescent protein insterted into human rhodopsin. We found that mutations that cause ADRP are usually misfolded and retained in endoplasmic reticulum and thus have low efficiency of 11-cis-retinal binding. And G90D mutant (causing CNSB) that was considered to have correct protein folding, however, showed an astonishing tendency to form inclusion bodies in our study, which may be related with its interrupted glycosylation in Golgi apparatus. In a word, we have established an effective and convenient system to investigate rhodopsin synthesis and transportation both in vitro and in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.